#CellXC #Culevit #renewed
Cell XC
Your cells divide, reproduce and die throughout your life. However, from time to time, errors may occur in their operation, resulting in faulty cells. A healthy person’s body takes care of these defective cells, correcting them. But in a stressed body, mistakes can even creep into this process.
In such cases, it is extremely important that the body receives the nutrients it needs. Until now, this has been the goal of our successful Culevit product, which will now be available online as CellXC.
More natural excipients
We have not changed the popular active ingredients, but we have worked on using the most natural excipients possible.
The development didn’t stop there as we also replaced tablets with capsules to make them easier to swallow. Moreover, the product contains vegetable gelatin instead of the previously used substance of animal origin to satisfy customers leading a vegetarian lifestyle.
Together for cell regeneration
Don’t think twice, choose Cell XC from now on, because it still contains such a unique combination of amino acids and vitamins, which especially helps in the regeneration of the body in case of significant weakness, poor general condition and after various surgeries and injuries. The active ingredients it contains are particularly important to prevent irregular cell division, thus supporting the strengthening of the body, which is why it can complement various therapies that improve the quality of life.
Active ingredients/CellXC capsule:
vitamin c………………………………………………….30.00 mg
Vitamin B6…………………………………………………….1.00 mg
Vitamin B2……………………………………………………….0.80 mg
Biotin………………………………………………………………0.03 mg
arginine…………………………………………………78.39 mg
Phenylalanine………………………………………………33.04 mg
Histidine………………………………………………………..31.03 mg
Methionine…………………………………………………….29.84 mg
Tryptophan……………………………………………….15.32 mg
Tyrosine……………………………………………………..1.27 mg
Malic acid…………………………………………………….23.47 mg
adenine……………………………………………………..2.26 mg
Article CellXC – Culevit renewed! comes from the Calivita website.
